208 related articles for article (PubMed ID: 31245174)
1. Mir-421 in plasma as a potential diagnostic biomarker for precancerous gastric lesions and early gastric cancer.
Chen J; Wu L; Sun Y; Yin Q; Chen X; Liang S; Meng Q; Long H; Li F; Luo C; Xiao X
PeerJ; 2019; 7():e7002. PubMed ID: 31245174
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value and clinical significance of circulating miR-650 and CA211 in detecting of gastric carcinoma.
Chen J; Wu L; Sun Y; Luo C; Chen X; Wu L; Ding J; Pan G; Han C; Wu Z; Shen Y
Oncol Lett; 2020 Nov; 20(5):254. PubMed ID: 32994817
[TBL] [Abstract][Full Text] [Related]
3. Value of TCT combined with serum CA153 and CA50 in early diagnosis of cervical cancer and precancerous lesions.
Li H; Li L; Sun J; Dong S; Li H
Pak J Med Sci; 2022; 38(6):1471-1476. PubMed ID: 35991263
[TBL] [Abstract][Full Text] [Related]
4. Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric Cancer: A Multiphase Study.
Guo X; Lv X; Ru Y; Zhou F; Wang N; Xi H; Zhang K; Li J; Chang R; Xie T; Wang X; Li B; Chen Y; Yang Y; Chen L; Chen L
JAMA Surg; 2020 Jul; 155(7):572-579. PubMed ID: 32520332
[TBL] [Abstract][Full Text] [Related]
5. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.
Zhang J; Song Y; Zhang C; Zhi X; Fu H; Ma Y; Chen Y; Pan F; Wang K; Ni J; Jin W; He X; Su H; Cui D
Theranostics; 2015; 5(7):733-45. PubMed ID: 25897338
[TBL] [Abstract][Full Text] [Related]
6. Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer.
Valladares-Ayerbes M; Reboredo M; Medina-Villaamil V; Iglesias-Díaz P; Lorenzo-Patiño MJ; Haz M; Santamarina I; Blanco M; Fernández-Tajes J; Quindós M; Carral A; Figueroa A; Antón-Aparicio LM; Calvo L
J Transl Med; 2012 Sep; 10():186. PubMed ID: 22954417
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of serum miR-21 in breast cancer compared with CA153 and CEA.
Gao J; Zhang Q; Xu J; Guo L; Li X
Chin J Cancer Res; 2013 Dec; 25(6):743-8. PubMed ID: 24385703
[TBL] [Abstract][Full Text] [Related]
8. A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer.
Zhu C; Ren C; Han J; Ding Y; Du J; Dai N; Dai J; Ma H; Hu Z; Shen H; Xu Y; Jin G
Br J Cancer; 2014 Apr; 110(9):2291-9. PubMed ID: 24595006
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of circulating microRNA-130b and blood routine parameters in the early diagnosis of gastric cancer.
Chen J; Liu Z; Gao G; Mo Y; Zhou H; Huang W; Wu L; He X; Ding J; Luo C; Long H; Feng J; Sun Y; Guan X
Oncol Lett; 2021 Oct; 22(4):725. PubMed ID: 34429765
[TBL] [Abstract][Full Text] [Related]
10. Circulating miR-19a-3p and miR-483-5p as Novel Diagnostic Biomarkers for the Early Diagnosis of Gastric Cancer.
Cheng J; Yang A; Cheng S; Feng L; Wu X; Lu X; Zu M; Cui J; Yu H; Zou L
Med Sci Monit; 2020 Jun; 26():e923444. PubMed ID: 32487978
[TBL] [Abstract][Full Text] [Related]
11. Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection.
Li BS; Zhao YL; Guo G; Li W; Zhu ED; Luo X; Mao XH; Zou QM; Yu PW; Zuo QF; Li N; Tang B; Liu KY; Xiao B
PLoS One; 2012; 7(7):e41629. PubMed ID: 22860003
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of serum miR-17 and miR-106b levels in gastric cancer and benign gastric diseases.
Zeng Q; Jin C; Chen W; Xia F; Wang Q; Fan F; Du J; Guo Y; Lin C; Yang K; Li J; Peng X; Li X; Cao K
Chin J Cancer Res; 2014 Dec; 26(6):711-6. PubMed ID: 25561770
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of circulating miR-21 and miR-222 as diagnostic biomarkers for gastric cancer.
Emami SS; Nekouian R; Akbari A; Faraji A; Abbasi V; Agah S
J Cancer Res Ther; 2019; 15(1):115-119. PubMed ID: 30880765
[TBL] [Abstract][Full Text] [Related]
14. Circulating microRNA-196a/b are novel biomarkers associated with metastatic gastric cancer.
Tsai MM; Wang CS; Tsai CY; Huang CG; Lee KF; Huang HW; Lin YH; Chi HC; Kuo LM; Lu PH; Lin KH
Eur J Cancer; 2016 Sep; 64():137-48. PubMed ID: 27420607
[TBL] [Abstract][Full Text] [Related]
15. Droplet digital PCR-based circulating microRNA detection serve as a promising diagnostic method for gastric cancer.
Zhao G; Jiang T; Liu Y; Huai G; Lan C; Li G; Jia G; Wang K; Yang M
BMC Cancer; 2018 Jun; 18(1):676. PubMed ID: 29929476
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-421 is a new potential diagnosis biomarker with higher sensitivity and specificity than carcinoembryonic antigen and cancer antigen 125 in gastric cancer.
Wu J; Li G; Yao Y; Wang Z; Sun W; Wang J
Biomarkers; 2015 Feb; 20(1):58-63. PubMed ID: 25510566
[TBL] [Abstract][Full Text] [Related]
17. A new biomarker for the early diagnosis of gastric cancer: gastric juice- and serum-derived SNCG.
Pan Y; Zheng Y; Yang J; Wei Y; Wu H; Liu S; Yin A; Hu J; Zeng Y
Future Oncol; 2022 Sep; 18(28):3179-3190. PubMed ID: 35947016
[TBL] [Abstract][Full Text] [Related]
18. Decreased serum miR-181a is a potential new tool for breast cancer screening.
Guo LJ; Zhang QY
Int J Mol Med; 2012 Sep; 30(3):680-6. PubMed ID: 22692639
[TBL] [Abstract][Full Text] [Related]
19. Serum miR-515-3p, a potential new RNA biomarker, is involved in gastric carcinoma.
Han X; Li X; Zhao H; Zhou D; Sun B; Liu A; Zhang J; Cui Z; Ma X; Yuan L
J Cell Biochem; 2019 Sep; 120(9):15834-15843. PubMed ID: 31081157
[TBL] [Abstract][Full Text] [Related]
20. Changes in serum tumor markers in type 2 diabetes mellitus with microalbuminuria.
Chen L; Du S; Li YB; Su Q; Zhang J; Zhang H
Front Endocrinol (Lausanne); 2023; 14():1247099. PubMed ID: 38130399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
